Chronic pain treatment: The influence of tricyclic antidepressants on serotonin release and uptake in mast cells

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Ferjan, Ilonka ^a   Lipnik Štangelj, Metoda ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CALCIUM ION; CLOMIPRAMINE; DOXEPIN; IMIPRAMINE; SEROTONIN; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL CELL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CHRONIC PAIN; IN VITRO STUDY; MAST CELL; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SEROTONIN UPTAKE; SPECTROFLUOROMETRY; ANIMAL; CELL CULTURE; DRUG EFFECTS; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL; WISTAR RAT; DRUG EFFECT;

AMITRIPTYLINE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BIOLOGICAL TRANSPORT; CELLS, CULTURED; CHRONIC PAIN; CLOMIPRAMINE; IMIPRAMINE; MAST CELLS; RATS; RATS, WISTAR; SEROTONIN;

EID: 84877312978     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/340473     Document Type: Article

References (36)

1. Dharmshaktu P., Tayal V., Kalra B. S., Efficacy of antidepressants as analgesics: a review. Journal of Clinical Pharmacology 2012 52 1 6 17
2. + channels in injured and non-injured DRG neurons in the SNI model of neuropathic pain. Molecular and Cellular Neuroscience 2008 37 2 196 208 2-s2.0-38649087007 10.1016/j.mcn.2007.09.007 (Pubitemid 351173844)
3. Pertin M., Ji R. R., Berta T., Powell A. J., Karchewski L., Tate S. N., Isom L. L., Woolf C. J., Gilliard N., Spahn D. R., Decosterd I., Upregulation of the voltage-gated sodium channel β 2 subunit in neuropathic pain models: characterization of expression in injured and non-injured primary sensory neurons. Journal of Neuroscience 2005 25 47 10970 10980 2-s2.0-28044432745 10.1523/JNEUROSCI.3066-05.2005 (Pubitemid 41692627)
4. Lai J., Porreca F., Hunter J. C., Gold M. S., Voltage-gated sodium channels and hyperalgesia. Annual Review of Pharmacology and Toxicology 2004 44 371 397 2-s2.0-1342302379 10.1146/annurev.pharmtox.44.101802.121627 (Pubitemid 38263846)
5. McWilliams L. A., Cox B. J., Enns M. W., Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain 2003 106 1-2 127 133 2-s2.0-0142165203 10.1016/S0304-3959(03)00301- 4 (Pubitemid 37329622)
6. McWilliams L. A., Goodwin R. D., Cox B. J., Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain 2004 111 1-2 77 83 2-s2.0-4344702848 10.1016/j.pain.2004.06.002 (Pubitemid 39141009)
7. Von Korff M., Crane P., Lane M., Miglioretti D. L., Simon G., Saunders K., Stang P., Brandenburg N., Kessler R., Chronic spinal pain and physical-mental comorbidity in the United States: results from the national comorbidity survey replication. Pain 2005 113 3 331 339 2-s2.0-12344283765 10.1016/j.pain.2004.11.010 (Pubitemid 40127515)
8. Kirmayer L. J., Robbins J. M., Dworkind M., Yaffe M. J., Somatization and the recognition of depression and anxiety in primary care. American Journal of Psychiatry 1993 150 5 734 741 2-s2.0-0027240906 (Pubitemid 23137678)
9. Hudson J. I., Hudson M. S., Pliner L. F., Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. American Journal of Psychiatry 1985 142 4 441 446 2-s2.0-0021905414 (Pubitemid 15108206)
10. Woolf C. J., Evidence for a central component of post-injury pain hypersensitivity. Nature 1983 306 5944 686 688 2-s2.0-0021014399 (Pubitemid 14201852)
11. Cardenas D. D., Warms C. A., Turner J. A., Marshall H., Brooke M. M., Loeser J. D., Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial. Pain 2002 96 3 365 373 2-s2.0-0036222008 10.1016/S0304-3959(01)00483-3 (Pubitemid 34327885)
12. Cremon C., Carini G., Wang B., Vasina V., Cogliandro R. F., De Giorgio R., Stanghellini V., Grundy D., Tonini M., De Ponti F., Corinaldesi R., Barbara G., Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. The American Journal of Gastroenterology 2011 106 7 1290 1298 2-s2.0-79960055079 10.1038/ajg.2011.86
13. Mahjoub F. E., Farahmand F., Pourpak Z., Asefi H., Amini Z., Mast cell gastritis: children complaining of chronic abdominal pain with histologically normal gastric mucosal biopsies except for increase in mast cells, proposing a new entity. Diagnostic Pathology 2009 3 4, article 34 10.1186/1746-1596-4-34
14. Taylor T. J., Youssef N. N., Shankar R., Kleiner D. E., Henderson W. A., The association of mast cells and serotonin in children with chronic abdominal pain of unknown etiology. Biomed Central Research Notes 2010 21 3 265 10.1186/1756-0500-3-265
15. Park J. H., Rhee P. L., Kim H. S., Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. Journal of Gastroenterologa and Hepatology 2006 21 1 71 78
16. Moore R. A., Derry S., Aldington D., Cole P., Wiffen P. J., Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews 2012 12 12 CD008242 10.1002/14651858.CD008242.pub2
17. Finnerup N. B., Baastrup C., Spinal cord injury pain: mechanisms and management. Current Pain and Headache Reports 2012 16 3 207 216
18. Thakur R., Philip A. G., Chronic pain perspectives: treating herpes zoster and postherpetic neuralgia: an evidence-based approach. The Journal of Family Practice 2012 16 supplement 9 S9 S15
19. Nalamachu S., Morley-Forster P., Diagnosing and managing postherpetic neuralgia. Drugs and Aging 2012 29 11 863 869
20. Richards B. L., Whittle S. L., van der Heijde D. M., Buchbinder R., The efficacy and safety of antidepressants in inflammatory arthritis: a Cochrane systematic review. The Journal of Rheumatology 2012 90 supplement 1 21 27
21. Calandre E. P., Rico-Villademoros F., The role of antipsychotics in the management of fibromyalgia. CNS Drugs 2012 26 2 135 153
22. Ferjan I., Erjavec F., Changes in histamine and serotonin secretion from rat peritoneal mast cells caused by antidepressants. Inflammation Research 1996 45 3 141 144 2-s2.0-0029984638 10.1007/BF02265168 (Pubitemid 26097459)
23. Ferjan I., Erjavec F., Contribution of serotonin reuptake to differential histamine and serotonin secretion from rat peritoneal mast cells. Inflammation Research 1995 44 supplement 1 S28 S29 2-s2.0-0028955136
24. Erjavec F., Ferjan I., Characteristics of histamine and serotonin release from rat mast cells induced by thymic peptides. Agents and Actions 1991 33 supplement 1 30 32 2-s2.0-0025869452
25. Phillips K., Clauw D. J., Central pain mechanisms in chronic pain states-maybe it is all in their head. Best Practice and Research. Clinical Rheumatology 2011 25 2 141 154
26. Barbara G., Stanghellini V., De Giorgio R., Cremon C., Cottrell G. S., Santini D., Pasquinelli G., Morselli-Labate A. M., Grady E. F., Bunnett N. W., Collins S. M., Corinaldesi R., Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004 126 3 693 702 2-s2.0-10744225624 10.1053/j.gastro.2003.11. 055 (Pubitemid 38298317)
27. Crowell M. D., Role of serotonin in the pathophysiology of the irritable bowel syndrome. British Journal of Pharmacology 2004 141 8 1285 1293 (Pubitemid 38638817)
28. Barbara G., Wang B., Stanghellini V., de Giorgio R., Cremon C., Di Nardo G., Trevisani M., Campi B., Geppetti P., Tonini M., Bunnett N. W., Grundy D., Corinaldesi R., Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007 132 1 26 37 2-s2.0-33846193703 10.1053/j.gastro.2006.11.039 (Pubitemid 46108761)
29. Costedio M. M., Hyman N., Mawe G. M., Serotonin and its role in colonic function and in gastrointestinal disorders. Diseases of the Colon and Rectum 2007 50 3 376 388 2-s2.0-33947174847 10.1007/s10350-006-0763-3 (Pubitemid 46394454)
30. Atkinson W., Lockhart S., Whorwell P. J., Keevil B., Houghton L. A., Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology 2006 130 1 34 43 2-s2.0-30044442329 10.1053/j.gastro.2005.09.031 (Pubitemid 43049833)
31. Houghton L. A., Atkinson W., Lockhart S., Whorwell P. J., Keevil B., Sigmoid-colonic motility in health and irritable bowel syndrome: a role for 5-hydroxytryptamine. Neurogastroenterology and Motility 2007 19 9 724 731 2-s2.0-34548188027 10.1111/j.1365-2982.2007.00943.x (Pubitemid 47312399)
32. Coates M. D., Mahoney C. R., Linden D. R., Sampson J. E., Chen J., Blaszyk H., Crowell M. D., Sharkey K. A., Gershon M. D., Mawe G. M., Moses P. L., Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004 126 7 1657 1664 2-s2.0-2942525747 10.1053/j.gastro.2004. 03.013 (Pubitemid 38736329)
33. Spiller R., Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease. Neurogastroenterology and Motility 2007 19 2 25 31 2-s2.0-34447136135 10.1111/j.1365-2982.2007.00965.x (Pubitemid 47037963)
34. Gershon M. D., Tack J., The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007 132 1 397 414 2-s2.0-33846347644 10.1053/j.gastro.2006.11.002 (Pubitemid 46127672)
35. De Giorgio R., Barbara G., Furness J. B., Tonini M., Novel therapeutic targets for enteric nervous system disorders. Trends in Pharmacological Sciences 2007 28 9 473 481 2-s2.0-34548400223 10.1016/j.tips.2007.08.003 (Pubitemid 47368703)
36. Dunlop S. P., Coleman N. S., Blackshaw E., Perkins A. C., Singh G., Marsden C. A., Spiller R. C., Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clinical Gastroenterology and Hepatology 2005 3 4 349 357 2-s2.0-16844380691 10.1016/S1542-3565(04)00726-8 (Pubitemid 40488343)